Zuga Matt - Insider Non-Derivative Transactions at Acumen Pharmaceuticals, Inc. (ABOS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 23, 2025, Zuga Matt's relationship to Acumen Pharmaceuticals, Inc. (ABOS) is Officer (CFO & Chief Business Officer), and currently has 231,744 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABOS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Zuga Matt - Insider Non-Derivative Transactions of ABOS Common Stock

Zuga Matt - Insider Non-Derivative Transactions at ABOS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 24, 2025	Sell -- (Common Stock)	28902	1.72	231744
Jan 22, 2025	Sell -- (Common Stock)	4364	1.6	260646
Jan 7, 2025	Acquisition -- (Common Stock)	66800	0	265010
Jan 4, 2025	Sell -- (Common Stock)	13235	1.84	198210
Jan 19, 2024	Sell -- (Common Stock)	4242	3.71	211445
Jan 3, 2024	Acquisition -- (Common Stock)	106000	0	215687
Jan 18, 2023	Acquisition -- (Common Stock)	33500	0	109687
Dec 30, 2022	M -- (Common Stock)	50000	1.19	76187